Copyright
©The Author(s) 2015.
World J Gastroenterol. May 21, 2015; 21(19): 5979-5984
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.5979
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.5979
Table 4 Hematologic adverse events during the first cycle
| Level 0 | (n = 3) | Level 1 | (n = 6) | Level 2 | (n = 3) | |
| Gr 1-2 | Gr 3-4 | Gr 1-2 | Gr 3-4 | Gr 1-2 | Gr 3-4 | |
| Neutropenia | 0 | 0 | 0 | 1 | 0 | 1 |
| Leucopenia | 1 | 0 | 2 | 1 | 1 | 0 |
| Thrombocytopenia | 2 | 0 | 1 | 1 | 0 | 0 |
| Anemia | 2 | 0 | 1 | 0 | 0 | 0 |
| Febrile neutropenia | NA | 0 | NA | 1 | NA | 0 |
- Citation: Watanabe A, Kida M, Miyazawa S, Iwai T, Okuwaki K, Kaneko T, Yamauchi H, Takezawa M, Imaizumi H, Koizumi W. Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer. World J Gastroenterol 2015; 21(19): 5979-5984
- URL: https://www.wjgnet.com/1007-9327/full/v21/i19/5979.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i19.5979